(Q37210063)

19 August 2017

1 reference

title

Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease (English)

1 reference

19 August 2017

0 references

1

Harald Hampel

1 reference

19 August 2017

Yong Shen

2

1 reference

19 August 2017

publication date

1 January 2009

1 reference

Scandinavian Journal of Clinical and Laboratory Investigation

19 August 2017

published in

1 reference

19 August 2017

volume

69

1 reference

19 August 2017

issue

1

1 reference

19 August 2017

page(s)

8-12

1 reference

Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365510701864610

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701864610

Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701864610

Purification and cloning of amyloid precursor protein beta-secretase from human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701864610

APP processing is regulated by cytoplasmic phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701864610

Characterization of Alzheimer's beta -secretase protein BACE. A pepsin family member with unusual properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701864610

Maturation and pro-peptide cleavage of beta-secretase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701864610

Closing in on the amyloid cascade: recent insights into the cell biology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701864610

Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701864610

Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701864610

Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701864610

Levels of beta-secretase BACE and alpha-secretase ADAM10 mRNAs in Alzheimer hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701864610

CSF BACE1 activity is increased in CJD and Alzheimer disease versus [corrected] other dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701864610

Detection of a soluble form of BACE-1 in human cerebrospinal fluid by a sensitive activity assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701864610

Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701864610

CSF Abeta42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701864610

Vascular risk factors, incidence of MCI, and rates of progression to dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701864610

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701864610

Cerebrospinal fluid tau protein and periventricular white matter lesions in patients with mild cognitive impairment: implications for 2 major pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701864610

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701864610

Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: a population-based study in 85-year-olds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701864610

Design and analysis of genetic association studies to finely map a locus identified by linkage analysis: sample size and power calculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701864610

Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701864610

Phosphorylated tau predicts rate of cognitive decline in MCI subjects: a comparative CSF study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701864610

Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701864610

Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701864610

Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701864610

10.1080/00365510701864610

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference